Evaluation of the protective effects of all-trans-astaxanthin on canine osteosarcoma cell lines

American Journal of Veterinary Research

Volumn 71, Issue 1, 2010, Pages 89-96

  Wakshlag, Joseph J ^a   Balkman, Cheryl A ^a   Morgan, Stewart K ^a   McEntee, Margaret C ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AGAR; ASTAXANTHIN; CONNEXIN 43; DOXORUBICIN; HYDROGEN PEROXIDE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL DEATH; CELL FUNCTION; CELL GROWTH; CELL KINETICS; CELL LINE; CELL PROLIFERATION; CELL STRESS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DOG; GROWTH CURVE; IN VITRO STUDY; IRRADIATION; NONHUMAN; OSTEOSARCOMA CELL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CELL LINE, TUMOR; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FURANS; OSTEOSARCOMA; TIME FACTORS; XANTHOPHYLLS;

CANIS FAMILIARIS;

EID: 75749091444     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.1.89     Document Type: Article

References (35)

1. Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol 2003;21:210-216.
2. Higuera-Ciapara I, Félix-Vanenzuela L, Goycoolea FM. Astaxanthin: a review of its chemistry and applications. Crit Rev Food Sci Nutr 2006;46:185-196.
3. Schroeder WA, Johnson EA. Singlet oxygen and peroxyl radicals regulate carotenoid biosynthesis in Phaffia rhodozyma. J Biol Chem 1995;270:18374-18379.
4. Liu X, Osawa T. Cis astaxanthin and especially 9-cis astaxanthin exhibits a higher antioxidant activity in vitro compared to the all-trans isomer. Biochem Biophys Res Commun 2007;357:187-193.
5. Hussein G, Sankawa U, Goto H, et al. Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod 2006;69:443-449.
6. Jyonouchi H, Sun S, Iijima K, et al. Antitumor activity of astaxanthin and its mode of action. Nutr Cancer 2000;36:59-63.
7. Gross GJ, Lockwood SE Acute and chronic administration of disodium disuccinate astaxanthin (Cardax) produces marked cardioprotection in dog hearts. Mol Cell Biochem 2005;272:221-227.
8. Ikeuchi M, Koyama T, Takahashi J, et al. Effects of astaxan-thin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem 2007;71:893-899.
9. Jyonouchi H, Hill RJ, Tomita Y, et al. Studies of immunomodulating actions of carotenoids. 1. Effects of β-carotene and astaxanthin on murine lymphocyte functions and cell surface marker expression in in vitro culture system. Nutr Cancer 1991;16:93-105.
10. Bertram JS, Vine AL. Cancer prevention by retinoids and carotenoids: independent action on a common target. Biochim Biophys Acta 2005;1740:170-178.
11. Lockwood SF, Jackson HL, Gross GJ. Retrometabolic synthases of astaxanthin conjugates (3,3′-dihydroxy-β,β-carotene-4,4′- di-one): a novel approach to oral and parenteral cardioprotection. Cardiovasc Hematol Agents Med Chem 2006;4:335-349.
12. Tanaka T, Kawamori T, Ohnishi M, et al. Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis 1995;16:2957-2963.
13. Tanaka T, Makita H, Ohnishi M, et al. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res 1995;55:4059-4064.
14. Tanaka T, Morishita Y, Suzui M, et al. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis 1994;15:15-19.
15. Chew BP, Park JS, Wong MW, et al. A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res 1999;19:1849-1853.
16. Hix LM, Frey DA, McLaws MD, et al. Inhibition of chemically-induced neoplastic transformation by a novel tetrasodium diphosphate astaxanthin derivative. Carcinogenesis 2005;26:1634-1641.
17. King TJ, Bertram JS. Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta 2005;1719:146-160.
18. Lordan S, O'Neill C, O'Brien NM. Effects of apigenin, lycopene and astaxanthin on 7 beta-hyroxycholesterol-induced apoptosis and Akt phosphorylation in U937 cells. Br J Nutr 2008;100:287-296.
19. Lee SJ, Bai SK, Lee KS, et al. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IKB kinase-dependent NF-κB activation. Mol Cells 2003;16:97-105.
20. Lana SE, Kogan LR, Crump KA, et al. The use of complementary and alternative therapies in dogs and cats with cancer. J Am Anim Hosp Assoc 2006;42:361-365.
21. Prasad KN, Cole WC, Kumar B, et al. Pros and cons of antioxidant use during radiation therapy. Cancer Treat Rev 2002;28:7991.
22. Lawenda BD, Kelly KM, Ladas EJ, et al. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 2008;100:773-783.
23. Cooney RV, Kappock TJ, Pung A, et al. Solubilization, cellular uptake, and activity of β-carotene and other carotenoids as inhibitors of neoplastic transformation in cell culture. Methods Enzymol 1993;214:55-68.
24. 1-42-induced apoptosis. Protein J 2006;25:83-94.
25. Patterson SD. Protein concentration determination. In: Spector DL, Goldman RD, Leinwand LA, eds. Cells: a laborotory manual. Culture and biochemical analysis of cells. Vol 1. Plainview, NY: Cold Spring Harbor Press, 1997;56.1-56.5.
26. Amano Y, Fukumoto S. A study on the cell kinetics of the canine mucosa by the cytofluorometric method: an evaluation of chemically induced gastric cancer. Gastroenterol Jpn 1987;22:292-302.
27. Antonyak MA, Miller AM, Jansen JM, et al. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J Biol Chem 2004;279:41461-41467.
28. Wang JB, Wu WJ, Cerione RA. Cdc42 and Ras cooperate to mediate cellular transformation by intersectin-L. J Biol Chem 2005;280:22883-22891.
29. Anderson ML. A preliminary investigation of the enzymatic inhibition of 5α-reductase and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and saw palmetto lipid extract in vitro. J Herb Pharmacother 2005;5:17-26.
30. Teo IT, Chui CH, Tang JC, et al. Antiproliferation and induction of cell death of Phaffia rhodozyma (Xanthophyllomyces dendrorhous) extract fermented by brewer malt waste on breast cancer cells. Int J Mol Med 2005;16:931-936.
31. Briviba K, Bornemann R, Lemmer U. Visualization of astaxanthin localization in HT29 human colon adenocarcinoma cells by combined confocal resonance Raman and fluorescence microspectroscopy. Mol Nutr Food Res 2006;50:991-995.
32. Ben-Dor A, Steiner M, Gheber L, et al. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 2005;4:177-186.
33. Chun R, Garrett LD, Vail DM. Cancer chemotherapy. In: Withrow SJ, Vail DM, eds. Small animal clinical oncology. 4th ed. St Louis: Saunders, 2007;163-191.
34. Santocono M, Zurria M, Berrettini M, et al. Influence of astaxanthin, zeaxanthin, and lutein on DNA damage and repair in UVA-irradiated cells. J Photochem Photobiol B 2006;85:205-215.
35. Mortensen A, Skibsted H, Truscott TG. The interaction of di-etary carotenoids with radical species. Arch Biochem Biophys 2001;385:13-19.